This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3isq
From Proteopedia
m (Protected "3isq" [edit=sysop:move=sysop]) |
Revision as of 18:07, 24 March 2013
Contents |
Crystal structure of human 4-Hydroxyphenylpyruvate dioxygenase
Disease
[HPPD_HUMAN] Defects in HPD are the cause of tyrosinemia type 3 (TYRO3) [MIM:276710]. TYRO3 is an inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, seizures and mild mental retardation.[1][2] Defects in HPD are a cause of hawkinsinuria (HAWK) [MIM:140350]. HAWK is an inborn error of tyrosine metabolism characterized by failure to thrive, persistent metabolic acidosis, fine and sparse hair, and excretion of the unusual cyclic amino acid metabolite, hawkinsin, in the urine.[3]
Function
[HPPD_HUMAN] Key enzyme in the degradation of tyrosine.
About this Structure
3isq is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Ruetschi U, Cerone R, Perez-Cerda C, Schiaffino MC, Standing S, Ugarte M, Holme E. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III. Hum Genet. 2000 Jun;106(6):654-62. PMID:10942115
- ↑ Tomoeda K, Awata H, Matsuura T, Matsuda I, Ploechl E, Milovac T, Boneh A, Scott CR, Danks DM, Endo F. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab. 2000 Nov;71(3):506-10. PMID:11073718 doi:10.1006/mgme.2000.3085
- ↑ Tomoeda K, Awata H, Matsuura T, Matsuda I, Ploechl E, Milovac T, Boneh A, Scott CR, Danks DM, Endo F. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab. 2000 Nov;71(3):506-10. PMID:11073718 doi:10.1006/mgme.2000.3085
Categories: 4-hydroxyphenylpyruvate dioxygenase | Homo sapiens | Arrowsmith, C H. | Bountra, C. | Bray, J E. | Cocking, R. | Delft, F von. | Edwards, A. | Kavanagh, K L. | Krojer, T. | Oppermann, U. | Pike, A C.W. | Pilka, E S. | SGC, Structural Genomics Consortium. | Shafqat, N. | Weigelt, J. | Yue, W W. | Dioxygenase | Disease mutation | Hydroxyphenylpyruvate | Iron | Mental retardation | Metal-binding | Oxidoreductase | Phenylalanine catabolism | Phosphoprotein | Sgc | Structural genomic | Structural genomics consortium | Tyrosine catabolism | Tyrosine metabolism
